ATE172716T1 - Arylbenzoylguanidine - Google Patents

Arylbenzoylguanidine

Info

Publication number
ATE172716T1
ATE172716T1 AT95113105T AT95113105T ATE172716T1 AT E172716 T1 ATE172716 T1 AT E172716T1 AT 95113105 T AT95113105 T AT 95113105T AT 95113105 T AT95113105 T AT 95113105T AT E172716 T1 ATE172716 T1 AT E172716T1
Authority
AT
Austria
Prior art keywords
ch2f
chf2
halogen
ch2cf3
opt
Prior art date
Application number
AT95113105T
Other languages
German (de)
English (en)
Inventor
Rolf Dr Gericke
Dieter Dr Dorsch
Manfred Dr Baumgarth
Klaus-Otto Dr Minck
Norbert Dr Beier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of ATE172716T1 publication Critical patent/ATE172716T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/48Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C317/50Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Electroluminescent Light Sources (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95113105T 1994-08-28 1995-08-21 Arylbenzoylguanidine ATE172716T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4430213A DE4430213A1 (de) 1994-08-28 1994-08-28 Arylbenzoylguanidine

Publications (1)

Publication Number Publication Date
ATE172716T1 true ATE172716T1 (de) 1998-11-15

Family

ID=6526570

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95113105T ATE172716T1 (de) 1994-08-28 1995-08-21 Arylbenzoylguanidine

Country Status (20)

Country Link
US (1) US5807896A (https=)
EP (1) EP0699660B1 (https=)
JP (1) JPH0859598A (https=)
KR (1) KR960007540A (https=)
CN (1) CN1055919C (https=)
AT (1) ATE172716T1 (https=)
AU (1) AU704630B2 (https=)
BR (1) BR9503810A (https=)
CA (1) CA2156960A1 (https=)
CZ (1) CZ289058B6 (https=)
DE (2) DE4430213A1 (https=)
ES (1) ES2125537T3 (https=)
HU (1) HU216833B (https=)
NO (1) NO305242B1 (https=)
PL (1) PL180872B1 (https=)
RU (1) RU2153490C2 (https=)
SK (1) SK281135B6 (https=)
TW (1) TW386988B (https=)
UA (1) UA44237C2 (https=)
ZA (1) ZA957163B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4328352A1 (de) 1993-08-24 1995-03-02 Hoechst Ag Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
NZ314105A (en) * 1996-02-02 1997-12-19 Sumitomo Pharma Guanidine derivative substituted with a substituted indole which is peri condensed with a heterocyclic ring
DE19608161A1 (de) * 1996-03-04 1997-09-11 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19624178A1 (de) * 1996-06-18 1998-01-08 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19819548A1 (de) * 1998-04-30 1999-11-04 Merck Patent Gmbh Biphenylderivate
DE19833118C2 (de) * 1998-07-23 2000-07-27 Merck Patent Gmbh Verfahren zur Herstellung von orthoalkylierten Benzoesäurederivaten
GB0225548D0 (en) * 2002-11-01 2002-12-11 Glaxo Group Ltd Compounds
ATE440827T1 (de) * 2002-12-04 2009-09-15 Ore Pharmaceuticals Inc Melanocortin-rezeptormodulatoren
GB0323581D0 (en) * 2003-10-08 2003-11-12 Glaxo Group Ltd Novel compounds
GB0323584D0 (en) * 2003-10-08 2003-11-12 Glaxo Group Ltd Compounds
GB0323585D0 (en) * 2003-10-08 2003-11-12 Glaxo Group Ltd Compounds
GB0410121D0 (en) * 2004-05-06 2004-06-09 Glaxo Group Ltd Compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3420874A (en) * 1962-09-28 1969-01-07 Standard Oil Co Amine addition salts of nitro-carboxyalkali metal phenolates
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
ES2089600T3 (es) * 1992-02-15 1996-10-01 Hoechst Ag Benzoilguanidina sustituida en 3,5, con efecto antiarritmico y efecto inhibidor de la proliferacion de celulas.
CZ284456B6 (cs) * 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
DK0556673T3 (da) * 1992-02-15 1998-04-14 Hoechst Ag o-Substituerede benzoylguanidiner til behandling og profylakse af hjerterytmeforstyrrelser og iskæmisk inducerede skader samt til inhiberering af celleproliferation
ATE144248T1 (de) * 1992-07-01 1996-11-15 Hoechst Ag 3,4,5-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament
TW250477B (https=) * 1992-12-15 1995-07-01 Hoechst Ag
ES2100435T3 (es) * 1992-12-16 1997-06-16 Hoechst Ag Aminobenzoilguanidinas 3,5-sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene.
EP0604852A1 (de) * 1992-12-28 1994-07-06 Hoechst Aktiengesellschaft 2,4-Substituierte 5-(N-substituierte-Sulfamoyl)-Benzoylguanidine, als Antiarrythmika, Inhibitoren der Proliferationen von Zellen, und Inhibitoren des Natrium-Protonen-Antiporters
DK0612723T3 (da) * 1993-02-20 1998-03-30 Hoechst Ag Substituerede benzoylguanidiner, fremgangsmåde til fremstilling, deres anvendelse som lægemiddel, som inhibitor af den cellulære Na+/H+-udbytning eller som diagnostikum samt lægemiddel med indhold deraf
DE4318756A1 (de) * 1993-06-05 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
ES2125537T3 (es) 1999-03-01
NO953351D0 (no) 1995-08-25
UA44237C2 (uk) 2002-02-15
CZ218295A3 (en) 1996-03-13
CN1055919C (zh) 2000-08-30
KR960007540A (ko) 1996-03-22
EP0699660A3 (https=) 1996-03-20
CZ289058B6 (cs) 2001-10-17
NO953351L (no) 1996-02-29
PL310193A1 (en) 1996-03-04
CA2156960A1 (en) 1996-03-01
HU216833B (hu) 1999-09-28
EP0699660A2 (de) 1996-03-06
BR9503810A (pt) 1996-04-16
CN1117962A (zh) 1996-03-06
PL180872B1 (pl) 2001-04-30
RU2153490C2 (ru) 2000-07-27
EP0699660B1 (de) 1998-10-28
DE59504053D1 (de) 1998-12-03
SK281135B6 (sk) 2000-12-11
TW386988B (en) 2000-04-11
HU9502516D0 (en) 1995-10-30
ZA957163B (en) 1996-04-17
SK105395A3 (en) 1996-03-06
JPH0859598A (ja) 1996-03-05
AU3014495A (en) 1996-03-14
HUT72303A (en) 1996-04-29
NO305242B1 (no) 1999-04-26
US5807896A (en) 1998-09-15
AU704630B2 (en) 1999-04-29
DE4430213A1 (de) 1996-02-29

Similar Documents

Publication Publication Date Title
DE59504053D1 (de) Arylbenzoylguanidine
BR9503817A (pt) Derivados de ácido benzóico orto-substituídos processo para sua preparação processo para a produção de uma preparação farmacêutica preparação farmacêutica e uso
DK0707007T3 (da) Amino(thio)etherderivater som CNS-aktive midler
DK0783500T3 (da) Aminoheterocykliske derivater som antithrombotiske eller antikoagulerende midler
FI955024A0 (fi) Uudet piperidiiniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
BR9503881A (pt) Heterociclilbenzoilguanidina processo para sua preparação processo para a produção de preparações farmacêuticas preparações farmacêuticas e utilização
ATE107499T1 (de) Haarkräftigungsmittel.
PT94085A (pt) Processo para a preparacao de derivados de amino-fenol anti-inflamatorios
FI914717A0 (fi) Kanalbytesfoerfarande som minimerar stoerningar i dtmf-signalering i ett cellulaert radiosystem.
FI862868A0 (fi) Nya aminofenoler och deras anvaendning i oxiderbara haorfaergmedel.
NO802102L (no) Trijoderte baser.
FI885454A0 (fi) Administrationssystem, som laongsamt frigoer substituerade dihydropyridiner.
IS4725A (is) Afleiður amidíns og ísóþíóþvagefnis er hindra nítrítoxíðsyntasa
DE3779187D1 (de) 2-trifluormethyl-benzimidazole.
DK540684A (da) Benzoquinoliziner
IT8421432A0 (it) Composti costituiti da 5-ammino-3-osso-4-(sostituito-fenil)-2,3-diidrofurano e suoi derivati, con proprieta' erbicide e di regolazione della crescita delle piante.
ES523426A0 (es) Un metodo para preparar nuevos derivados de guanina
ITMI921855A1 (it) Derivati di catecolammine, processo per la loro preparazione e composizioni farmaceutiche che li contengono
FR2043463A1 (en) Benzoxazines and benzothiazines having c n s and
ES1006996Y (es) Disposicion elastica de paneles compactos para muros-cortina todo vidrio.
TW227527B (en) An aniline offshoot condenser's divergent agent and synthesizing method
IT9048605A0 (it) Derivati della 1,2,3,4,-tetraidronaftilammina ad attivita' nootropica e composizioni farmaceutiche che li contengono.
IT9053139V0 (it) Proiettore di fasci luminosi, in particolare per effetti scenografici
ES8604864A1 (es) Procedimiento para la obtencion de clorhidrato de 1-(2',6'- dimetilfenil)-3-metilamidinourea
ECSP951519A (es) Arilbenzoilguanidinas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee